Eric Dessertenne, Chief Operating Officer, will give a presentation at The Conference Session 2 on "Patient adherence: new challenges, new opportunities", Wednesday 1st at 2.40 PM. He will explain how connected devices can not only monitor treatment adherence but also guarantee better and safer treatment administration.
BIOCORP will also participate to the Innovation Gallery, introducing NEWGUARD, a new generation integrated passive safety device compatible with various sizes of stacked needles PFS. This innovative solution creates new benefits for pharmaceutical companies in terms of supply chain, TCO and packaging. NEWGUARD meets both the economic criteria and the end users' protection requirements.
During 2 days, various members of BIOCORP's staff will be available to answer your questions and discuss about your future projects, including:
- Eric Dessertenne, Chief Operating Officer
- Thierry Guillemaut, Head of production
- Alain Marcoz, Head of software R&D
- Daniel Aneas, Head of product R&D
- Patrick Quero, Head of quality and regulatory affairs
